Emmaus Life Sciences, Inc. (EMMA) › Cost of RevenueEmmaus Life Sciences, Inc. (EMMA) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2014: $73.0K2015: $4.9K2016: $5.5K2017: $53.5K2018: $993.0K2019: $1.09M2020: $2.25M2021: $3.31M2022: $2.59M2023: $1.34M2024: $1.20M2025: $857.0K$857.0K2014Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$857.0K-28.6%2024$1.20M-10.5%2023$1.34M-48.1%2022$2.59M-21.9%2021$3.31M+47.3%2020$2.25M+105.5%2019$1.09M+10.2%2018$993.0K+1756.1%2017$53.5K+872.7%2016$5.5K+12.2%2015$4.9K-93.3%2014$73.0K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share